研究人员报告指出,长期暴露于化石燃料燃烧所产生的细悬浮微粒空气污染,与年长者的阿兹海默症风险存在直接关联,显示脑部健康可能比先前认为的更直接受到影响。该分析把人们多年来居住的地点与其所吸入的空气,连结到大脑如何老化,并置于美国污染与排放规则之环境政策变动的背景之下。
这项研究(周二发表于《PLOS Medicine》)分析了 2000 到 2018 年间 2800 万名 65 岁以上美国成人的健康与地理位置资料,发现细悬浮微粒浓度较高的邮递区号,失智症发生率也较高。平均暴露约为世界卫生组织建议年均值的 2x,而污染较重地区的人也有较高的高血压、中风与忧郁症比例,这些本身也是失智风险因子;然而,污染较重地区新增的阿兹海默症病例多数似乎独立于这些慢性疾病,支持(但未证明)更直接的「污染到失智」途径。
科学家提出可能机制,例如增加脑部发炎或促进有毒蛋白沉积;先前研究也指向异常蛋白团块(路易体,Lewy bodies)可能是其中的连结。主要限制在于,污染暴露与部分风险因子(例如吸烟与体重)是使用邮递区号或郡级资料估算,而非个人层级的量测,因而降低了因果确定性。即便如此,其规模(2800 万人、19 年)以及高于指引 2x 的暴露水准,仍凸显其对失智与其他高成本疾病在族群层面的潜在影响,这些疾病会影响失能、早逝与独立生活能力。
Researchers report a direct association between long-term exposure to fine particulate air pollution from fossil-fuel combustion and Alzheimer’s risk in older adults, suggesting brain health may be affected more directly than previously thought. The analysis links where people live and what they breathe over many years to how their brains age, in the context of shifting US environmental policy on pollution and emissions rules.
The study (published Tuesday in PLOS Medicine) analyzed health and location data for 28 million US adults aged over 65 years across 2000 to 2018, finding higher dementia incidence in postcodes with higher fine-particle concentrations. Average exposures were about 2x the World Health Organization’s recommended annual level, and people in more polluted areas also had higher rates of hypertension, stroke, and depression, which are themselves dementia risk factors; however, most of the additional Alzheimer’s cases in polluted areas appeared independent of these chronic conditions, supporting (but not proving) a more direct pollution-to-dementia pathway.
Scientists propose mechanisms such as increased brain inflammation or promotion of toxic protein deposits, with prior work pointing to abnormal protein clumps (Lewy bodies) as a possible link. Key caveats are that pollution exposure and some risk factors (for example smoking and weight) were estimated using postcode or county-level data rather than individual measurements, limiting causal certainty. Even so, the scale (28 million people over 19 years) and the 2x-above-guideline exposure levels reinforce the potential population-level impact on dementia and other costly morbidities affecting disability, early death, and independence.